Effects of Urban Afforestation Activity on Mood, Stress, and Anxiety

NCT05384301 | Completed

• 1 other identifier: AfforestMood
• Study Type: interventional
• Target: 154
• Locations: 1 country
• Sites: 1

Brief Summary

This single-group pretest-posttest clinical trial aims to evaluate the effects of a single-session afforestation activity on mood, stress, and anxiety in a sample of adults.

Conditions

Healthy

Keywords

Green spaces; Nature-based activities; Urban afforestation; Horticultural therapy; Mental health; Mood; Stress; Anxiety

Outcome Measures

Primary Outcomes (1)

• Mood

  The Spanish adaptation of the 30-item Short Form of the Profile of Mood States will be utilised. There are five questions situated under each mood factor of Anger, Fatigue, Vigour, Friendliness, Tension, and Depressed Mood, which will be rated on a five-point scale starting from 0 indicating "not at all" up to 4 indicating "a lot" to evaluate the current feelings. Higher scores on the vigour and friendliness subscale indicate more positive mood, and higher scores on the remaining subscales indicate more negative mood.

  Change from baseline the total mood disturbance after 90 minutes.

Secondary Outcomes (2)

• State stress

  Change from baseline state stress after 90 minutes.

• State anxiety

  Change from baseline state anxiety after 90 minutes.

Study Arms (1)

Urban Afforestation Group

EXPERIMENTAL

Participants will perform an afforestation activity with a duration of 90 minutes.

Other: Urban Afforestation Program

Interventions

Urban Afforestation Program OTHER

An afforestation program based on land cultivation and transplantation of several plants for 90 minutes will be implemented.

Also known as: Nature-based activity, Afforestation activity

Urban Afforestation Group

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Adults between 18 and 65 years.
• Any sex and gender.

You may not qualify if:

• Intake of any psychotropic medication.
• Other severe or medically unstable diseases that may interfere with participation.
• Severe cognitive impairment (Mini-Mental State Examination score \< 17 out of 30 points).
• Severe mental disorders in the acute phase or symptomatic phase.
• Severe intellectual disability.
• Behavioural alterations as this may interfere with their participation.

Sponsors & Collaborators

• Universidad de Granada: lead

Study Sites (1)

University of Granada, Faculty of Health Sciences

Granada, Andalusia, 18071, Spain

Location

MeSH Terms

Conditions

Psychological Well-Being; Anxiety Disorders

Condition Hierarchy (Ancestors)

Personal Satisfaction; Behavior; Mental Disorders

Study Officials

• José Manuel PÉREZ-MÁRMOL, PhD

  Associate Professor

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associate Professor

Study Record Dates

• First Submitted: May 17, 2022
• First Posted: May 20, 2022
• Study Start: May 25, 2022
• Primary Completion: June 5, 2022
• Study Completion: June 5, 2022
• Last Updated: June 7, 2022

Record last verified: 2022-06

Data Sharing

• IPD Sharing: Will not share

Locations

ES (1)